Market Trends of Embolic Protection Systems Industry
Cardiovascular Disease Segment is Expected to Witness a Notable Growth Over the Forecast period
The cardiovascular disease segment is expected to witness significant growth in the studied market owing to the factors such as an increase in cardiovascular diseases, and a rise in the adoption of embolic protection systems in cardiovascular therapies. For instance, as per the BHF fact sheet 2022, congenital heart disease is diagnosed in around 1 in 110 births globally, with more diagnoses later in life, that is an estimated 1.2 million babies a year. Similarly, according to the February 2023 update by AIHW, there were 146,000 coronary angiography procedures reported for patients admitted to hospitals in Australia, 97,200 (67%) for males and 48,900 (33%) for females during 2021-2021. Also, an increase in minimally invasive surgeries for heart diseases is expected to drive segment growth over the forecast period. For instance, as per the NICOR Adult Cardiac Surgery Report 2022, 19,333 adult heart operations were performed during the period of 2020-2021 across the United Kingdom. Thus, an increase in cardiac surgeries is expected to increase the demand for embolic protection systems and thereby boosting the segment growth over the forecast period.
Furthermore, in a survey conducted by JACC in February 2022, it was found that ECB can help in the reduction of stenosis rates and lower arterial host reaction compared to paclitaxel-coated balloons. Hence, such studies show the advantages offered by the ECB in cardiovascular disease, thereby increasing market growth in the studied segment. Moreover, in March 2022, Saint Luke's Health System sponsored a clinical trial to quantify the amount of debris captured by the SENTINEL transcatheter cerebral embolic protection (TCEP) device in patients undergoing valve in valve transcatheter aortic valve replacement (VIV TAVR) with bioprosthetic valvular fracture (BVF), Such clinical studies and researchers utilizing the embolic protection are estimated to increase the market growth.
Therefore, due to the rise in cardiac complications, the increase in cardiac surgery cases, and the increase in clinical studies associated with cardiovascular diseases utilizing embolic protection, the studied segment is expected to witness significant growth over the forecast period.
North America is Anticipated to Hold a Significant Market Share in the Embolic Protection Systems Market Over the Forecast Period
North America is expected to hold a significant market share in the overall embolic protection systems market, throughout the forecast period, mainly due to the high prevalence of cardiac and neurology diseases, an increase in healthcare expenditures, and the presence of key players.
The rise in the prevalence of cardiac complications among the North American population is expected to increase the demand for embolic protection systems. For instance, as per the July 2022 update from CIHI, about 2.4 million Canadians have heart disease. Hence, the high prevalence of the chronic disease is expected to utilize embolic protection systems over the forecast period. Also, research funding for heart and related diseases is expected to bolster the market growth in the North American region, over the forecast period. For instance, as per the May 2022 update by NIH, the estimated funding for Coronary Heart Disease research is USD 397 million in 2023. Thus, such research funding for heart diseases is estimated to bolster market growth over the forecast period.
Moreover, clinical studies relating to embolic protection conducted by organizations in the studied region are likely to drive market growth. For instance, as per the September 2022 update by Cleveland Clinic, findings from a Cleveland Clinic-led trial showed that a Cerebral Embolic Protection (CEP) device reduced the risk of disabling strokes by capturing and removing tiny pieces of calcium and other fragments resulting from transcatheter aortic valve replacement (TAVR) before they can reach the brain. Hence, owing to such advantages offered by embolic protection systems are expected to bolster the market growth over the forecast period.
Thus, due to the rise in cardiac and neurovascular diseases, and the increase in clinical studies associated with embolic protection, North America is expected to witness significant growth over the forecast period.
